메뉴 건너뛰기




Volumn 43, Issue 3, 2013, Pages 514-528

Therapy of adrenal insufficiency: An update

Author keywords

21 Hydroxylase autoantibodies; ACTH; Addison's disease; Congenital adrenal hyperplasia; Cortisone acetate; Fludrocortisone; Hydrocortisone

Indexed keywords

ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; CHRONOCORT; COLESTIPOL; CORTICOTROPIN; CORTISONE ACETATE; CYTOCHROME P450 3A4; DROSPIRENONE; ESTROGEN DERIVATIVE; ETOMIDATE; FLUDROCORTISONE; GLUCOCORTICOID; HYDROCORTISONE; METHYLPREDNISOLONE; MINERALOCORTICOID; POTASSIUM; PRASTERONE; RITUXIMAB; SODIUM; TAMOXIFEN; TOPIRAMATE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

EID: 84877875157     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9835-4     Document Type: Review
Times cited : (51)

References (166)
  • 1
    • 0030591713 scopus 로고    scopus 로고
    • Adrenal insufficiency
    • 8815944 1:STN:280:DyaK28zpvFShuw%3D%3D 10.1056/NEJM199610173351607
    • W. Oelkers, Adrenal insufficiency. N. Engl. J. Med. 335, 1206-1212 (1996)
    • (1996) N. Engl. J. Med. , vol.335 , pp. 1206-1212
    • Oelkers, W.1
  • 2
    • 0034918704 scopus 로고    scopus 로고
    • Clinical review 130: Addison's disease 2001
    • 11443143 1:CAS:528:DC%2BD3MXlt1Gjsrg%3D 10.1210/jc.86.7.2909
    • S. Ten, M. New, N. Maclaren, Clinical review 130: Addison's disease 2001. J. Clin. Endocrinol. Metab. 86, 2909-2922 (2001)
    • (2001) J. Clin. Endocrinol. Metab. , vol.86 , pp. 2909-2922
    • Ten, S.1    New, M.2    MacLaren, N.3
  • 3
    • 44649138430 scopus 로고
    • On the constitutional and local effects of disease of the supra-renal capsules. 1855. Reproduced in Dr. Addison's works
    • T. Addison, On the constitutional and local effects of disease of the supra-renal capsules. 1855. Reproduced in Dr. Addison's works. New Sydenham Soc. 36, 211-239 (1868)
    • (1868) New Sydenham Soc. , vol.36 , pp. 211-239
    • Addison, T.1
  • 4
    • 0031179296 scopus 로고    scopus 로고
    • The expanding world of primary adrenal insufficiencies
    • 9242192 1:CAS:528:DyaK2sXltVansrc%3D 10.1530/eje.0.1370010
    • P. Aubourg, The expanding world of primary adrenal insufficiencies. Eur. J. Endocrinol. 137, 10-12 (1997)
    • (1997) Eur. J. Endocrinol. , vol.137 , pp. 10-12
    • Aubourg, P.1
  • 5
    • 80051794531 scopus 로고    scopus 로고
    • Recent advances in the diagnosis and therapy of primary adrenal insufficiency
    • 1:CAS:528:DC%2BD3sXitlykuw%3D%3D
    • S. Laureti, F. Santeusanio, A. Falorni, Recent advances in the diagnosis and therapy of primary adrenal insufficiency. Curr. Med. Chem. 2, 251-258 (2002)
    • (2002) Curr. Med. Chem. , vol.2 , pp. 251-258
    • Laureti, S.1    Santeusanio, F.2    Falorni, A.3
  • 6
    • 0014403893 scopus 로고
    • Epidemiological and clinical picture of Addison's disease
    • 10.1016/S0140-6736(68)90948-3
    • A.S. Mason, T.W. Meade, J.A.H. Lee, J.N. Morris, Epidemiological and clinical picture of Addison's disease. Lancet II, 744-747 (1968)
    • (1968) Lancet , vol.2 , pp. 744-747
    • Mason, A.S.1    Meade, T.W.2    Lee, J.A.H.3    Morris, J.N.4
  • 7
    • 0016062612 scopus 로고
    • Addison's disease - Clinical studies. A report of 108 cases
    • 1:STN:280:DyaE2c7mvFSmsg%3D%3D
    • J. Nerup, Addison's disease - clinical studies. A report of 108 cases. Acta Endocrinol. (Copenh.) 76, 127-141 (1974)
    • (1974) Acta Endocrinol. (Copenh.) , vol.76 , pp. 127-141
    • Nerup, J.1
  • 8
    • 0033345815 scopus 로고    scopus 로고
    • Is the prevalence of Addison's disease underestimated?
    • 10323417 1:CAS:528:DyaK1MXjtFCksbY%3D 10.1210/jc.84.5.1762
    • S. Laureti, L. Vecchi, F. Santeusanio, A. Falorni, Is the prevalence of Addison's disease underestimated? J. Clin. Endocrinol. Metab. 84, 1762 (1999)
    • (1999) J. Clin. Endocrinol. Metab. , vol.84 , pp. 1762
    • Laureti, S.1    Vecchi, L.2    Santeusanio, F.3    Falorni, A.4
  • 9
    • 0028608804 scopus 로고
    • Eighty-six cases of Addison's disease
    • 1:STN:280:DyaK2M7ps1ehsg%3D%3D 10.1111/j.1365-2265.1994.tb02790.x
    • M.F. Kong, W. Jeffcoate, Eighty-six cases of Addison's disease. Clin. Endocrinol. (Oxf.) 41, 757-761 (1994)
    • (1994) Clin. Endocrinol. (Oxf.) , vol.41 , pp. 757-761
    • Kong, M.F.1    Jeffcoate, W.2
  • 10
    • 0030926893 scopus 로고    scopus 로고
    • The prevalence of Addison's disease in Coventry, UK
    • 9196701 1:STN:280:DyaK2szktVajsA%3D%3D 10.1136/pgmj.73.859.286
    • A.C. Willis, F.P. Vince, The prevalence of Addison's disease in Coventry, UK. Postgrad. Med. J. 73, 286-288 (1997)
    • (1997) Postgrad. Med. J. , vol.73 , pp. 286-288
    • Willis, A.C.1    Vince, F.P.2
  • 11
    • 18344403236 scopus 로고    scopus 로고
    • High prevalence and increasing incidence of Addison's disease in western Norway
    • 10.1046/j.1365-2265.2002.t01-1-01552.x
    • K. Løvas, E.S. Husebye, High prevalence and increasing incidence of Addison's disease in western Norway. Clin. Endocrinol. (Oxf.) 56, 787-791 (2002)
    • (2002) Clin. Endocrinol. (Oxf.) , vol.56 , pp. 787-791
    • Løvas, K.1    Husebye, E.S.2
  • 12
    • 85047684725 scopus 로고    scopus 로고
    • Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: Autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction
    • 12050123 1:CAS:528:DC%2BD38XltlWjtrk%3D 10.1210/er.23.3.327
    • C. Betterle, C. Dal Pra, F. Mantero, R. Zanchetta, Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr. Rev. 23, 327-364 (2002)
    • (2002) Endocr. Rev. , vol.23 , pp. 327-364
    • Betterle, C.1    Dal Pra, C.2    Mantero, F.3    Zanchetta, R.4
  • 14
    • 0026762562 scopus 로고
    • 21-Hydroxylase, a major autoantigen in idiopathic Addison's disease
    • 1351548 1:STN:280:DyaK38zgtFWhug%3D%3D 10.1016/0140-6736(92)91829-W
    • O. Winqvist, F.A. Karlsson, O. Kämpe, 21-Hydroxylase, a major autoantigen in idiopathic Addison's disease. Lancet 339, 1559-1562 (1992)
    • (1992) Lancet , vol.339 , pp. 1559-1562
    • Winqvist, O.1    Karlsson, F.A.2    Kämpe, O.3
  • 17
    • 0029116295 scopus 로고
    • High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase
    • 7673419 1:CAS:528:DyaK2MXotFyitb4%3D 10.1210/jc.80.9.2752
    • A. Falorni, A. Nikoshkov, S. Laureti et al., High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase. J. Clin. Endocrinol. Metab. 80, 2752-2755 (1995)
    • (1995) J. Clin. Endocrinol. Metab. , vol.80 , pp. 2752-2755
    • Falorni, A.1    Nikoshkov, A.2    Laureti, S.3
  • 18
    • 0028959484 scopus 로고
    • Immunoprecipitation assay for autoantibodies to steroid 21-hydroxylase in autoimmune adrenal diseases
    • 7882511 1:CAS:528:DyaK2MXksFWmurs%3D
    • J. Colls, C. Betterle, M. Volpato, L. Prentice, B.R. Smith, J. Furmaniak, Immunoprecipitation assay for autoantibodies to steroid 21-hydroxylase in autoimmune adrenal diseases. Clin. Chem. 41, 375-380 (1995)
    • (1995) Clin. Chem. , vol.41 , pp. 375-380
    • Colls, J.1    Betterle, C.2    Volpato, M.3    Prentice, L.4    Smith, B.R.5    Furmaniak, J.6
  • 19
    • 8244262431 scopus 로고    scopus 로고
    • Steroid 21-hydroxylase autoantibodies: Measurements with a new immunoprecipitation assay
    • 9141530 1:CAS:528:DyaK2sXjtVGmurs%3D 10.1210/jc.82.5.1440
    • H. Tanaka, M.S. Perez, M. Powell et al., Steroid 21-hydroxylase autoantibodies: measurements with a new immunoprecipitation assay. J. Clin. Endocrinol. Metab. 82, 1440-1446 (1997)
    • (1997) J. Clin. Endocrinol. Metab. , vol.82 , pp. 1440-1446
    • Tanaka, H.1    Perez, M.S.2    Powell, M.3
  • 20
    • 0242383226 scopus 로고    scopus 로고
    • Low prevalence of 21-hydroxylase antibodies in idiopathic Addison's disease from India
    • 1:CAS:528:DC%2BD3sXpsF2isr8%3D 10.1046/j.1365-2265.2003.01889.x
    • R. Nigam, E. Bhatia, D. Mei, L. Yu, A. Brozzetti, G.S. Eisenbarth, A. Falorni, Low prevalence of 21-hydroxylase antibodies in idiopathic Addison's disease from India. Clin. Endocrinol. 59, 593-598 (2003)
    • (2003) Clin. Endocrinol. , vol.59 , pp. 593-598
    • Nigam, R.1    Bhatia, E.2    Mei, D.3    Yu, L.4    Brozzetti, A.5    Eisenbarth, G.S.6    Falorni, A.7
  • 21
    • 2942615151 scopus 로고    scopus 로고
    • The endocrinology of adrenal tuberculosis: The effects of tuberculosis on the hypothalamo-pituitary-adrenal axis and adrenocortical function
    • 15233561 1:STN:280:DC%2BD2czjtFamtw%3D%3D
    • F. Kelestimur, The endocrinology of adrenal tuberculosis: the effects of tuberculosis on the hypothalamo-pituitary-adrenal axis and adrenocortical function. J. Endocrinol. Invest. 27, 380-386 (2004)
    • (2004) J. Endocrinol. Invest. , vol.27 , pp. 380-386
    • Kelestimur, F.1
  • 22
    • 0032940457 scopus 로고    scopus 로고
    • On the front of X-linked adrenoleukodystrophy
    • 10227684 1:CAS:528:DyaK1MXisFKjtbY%3D 10.1023/A:1022583813171
    • P. Aubourg, On the front of X-linked adrenoleukodystrophy. Neurochem. Res. 24, 515-520 (1999)
    • (1999) Neurochem. Res. , vol.24 , pp. 515-520
    • Aubourg, P.1
  • 23
    • 33847053927 scopus 로고    scopus 로고
    • DAX1: Increasing complexity in the roles of this novel nuclear receptor
    • 17210221 10.1016/j.mce.2006.12.017 1:CAS:528:DC%2BD2sXit12ms7c%3D
    • E.R. McCabe, DAX1: increasing complexity in the roles of this novel nuclear receptor. Mol. Cell. Endocrinol. 265-266, 179-182 (2007)
    • (2007) Mol. Cell. Endocrinol. , vol.265-266 , pp. 179-182
    • McCabe, E.R.1
  • 24
    • 0032990419 scopus 로고    scopus 로고
    • A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans
    • 10369247 1:CAS:528:DyaK1MXjvVelsLo%3D 10.1038/9629
    • J.C. Achermann, M. Ito, M. Ito, P.C. Hindmarsch, J.L. Jameson, A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat. Genet. 22, 125-126 (1999)
    • (1999) Nat. Genet. , vol.22 , pp. 125-126
    • Achermann, J.C.1    Ito, M.2    Ito, M.3    Hindmarsch, P.C.4    Jameson, J.L.5
  • 25
    • 0027396787 scopus 로고
    • Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor
    • 8094489 1:STN:280:DyaK3s7msVOktg%3D%3D 10.1016/0140-6736(93)90208-X
    • A.J. Clark, L. McLoughlin, A. Grossman, Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor. Lancet 341, 461-462 (1993)
    • (1993) Lancet , vol.341 , pp. 461-462
    • Clark, A.J.1    McLoughlin, L.2    Grossman, A.3
  • 26
    • 0029827345 scopus 로고    scopus 로고
    • Linkage of the gene for the triple A syndrome to chromosome 12q13 near the type II keratin gene cluster
    • 8968764 1:CAS:528:DyaK28XnsFOgtLg%3D 10.1093/hmg/5.12.2061
    • A. Weber, T.F. Wienker, M. Jung, D. Easton, H.J. Dean, C. Heinrichs, A. Reis, A.J. Clark, Linkage of the gene for the triple A syndrome to chromosome 12q13 near the type II keratin gene cluster. Hum. Mol. Genet. 5, 2061-2066 (1996)
    • (1996) Hum. Mol. Genet. , vol.5 , pp. 2061-2066
    • Weber, A.1    Wienker, T.F.2    Jung, M.3    Easton, D.4    Dean, H.J.5    Heinrichs, C.6    Reis, A.7    Clark, A.J.8
  • 27
    • 0029932498 scopus 로고    scopus 로고
    • Oxidative phosphorylation defect associated with primary adrenal insufficiency
    • 1:STN:280:DyaK283ht1ymsA%3D%3D 10.1016/S0022-3476(96)80136-3
    • K. North, M.S. Korson, N. Krawiecki, J.M. Shoffner, I.A. Holm, Oxidative phosphorylation defect associated with primary adrenal insufficiency. J. Pediatrics 128, 688-692 (1996)
    • (1996) J. Pediatrics , vol.128 , pp. 688-692
    • North, K.1    Korson, M.S.2    Krawiecki, N.3    Shoffner, J.M.4    Holm, I.A.5
  • 28
    • 0033582551 scopus 로고    scopus 로고
    • Adrenal insufficiency in Smith-Lemli-Opitz syndrome
    • 10069708 1:STN:280:DyaK1M7mslansw%3D%3D 10.1002/(SICI)1096-8628(19990219) 82:5<382: AID-AJMG5>3.0.CO;2-9
    • H.C. Andersson, J. Frentz, J.E. Martínez, C.M. Tuck-Muller, J. Bellizaire, Adrenal insufficiency in Smith-Lemli-Opitz syndrome. Am. J. Med. Genet. 82, 382-384 (1999)
    • (1999) Am. J. Med. Genet. , vol.82 , pp. 382-384
    • Andersson, H.C.1    Frentz, J.2    Martínez, J.E.3    Tuck-Muller, C.M.4    Bellizaire, J.5
  • 29
    • 21244480582 scopus 로고    scopus 로고
    • Primary adrenal insufficiency in children: Twenty years experience at the Sainte-Justine Hospital, Montreal
    • R. Perry, O. Kecha, J. Paquette, C. Huot, G. Van Vliet, C. Deal, Primary adrenal insufficiency in children: twenty years experience at the Sainte-Justine Hospital, Montreal. J. Clin. Endocrinol. Metab. 92, 4602-4608 (2005)
    • (2005) J. Clin. Endocrinol. Metab. , vol.92 , pp. 4602-4608
    • Perry, R.1    Kecha, O.2    Paquette, J.3    Huot, C.4    Van Vliet, G.5    Deal, C.6
  • 30
    • 0023925121 scopus 로고
    • The natural history of adrenal function in autoimmune patients with adrenal autoantibodies
    • 3392502 1:STN:280:DyaL1c3nsVaqsw%3D%3D 10.1677/joe.0.1170467
    • C. Betterle, C. Scalici, F. Presotto et al., The natural history of adrenal function in autoimmune patients with adrenal autoantibodies. J. Endocrinol. 117, 467-475 (1988)
    • (1988) J. Endocrinol. , vol.117 , pp. 467-475
    • Betterle, C.1    Scalici, C.2    Presotto, F.3
  • 32
    • 0345733740 scopus 로고    scopus 로고
    • I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: Markers of low progression to clinical Addison's disease
    • 9062509 1:CAS:528:DyaK2sXhsl2ns78%3D 10.1210/jc.82.3.932
    • C. Betterle, M. Volpato, B. Rees-Smith et al., I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison's disease. J. Clin. Endocrinol. Metab. 82, 932-938 (1997)
    • (1997) J. Clin. Endocrinol. Metab. , vol.82 , pp. 932-938
    • Betterle, C.1    Volpato, M.2    Rees-Smith, B.3
  • 33
    • 8044255852 scopus 로고    scopus 로고
    • Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: Markers of high progression to clinical Addison's disease
    • 9062510 1:CAS:528:DyaK2sXhsl2ntrc%3D 10.1210/jc.82.3.939
    • C. Betterle, M. Volpato, B. Rees Smith, J. Furmaniak, S. Chen, R. Zanchetta, N.A. Greggio, B. Pedini, M. Boscaro, F. Presotto II, Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease. J. Clin. Endocrinol. Metab. 82, 939-942 (1997)
    • (1997) J. Clin. Endocrinol. Metab. , vol.82 , pp. 939-942
    • Betterle, C.1    Volpato, M.2    Rees Smith, B.3    Furmaniak, J.4    Chen, S.5    Zanchetta, R.6    Greggio, N.A.7    Pedini, B.8    Boscaro, M.9    Presotto, I.I.F.10
  • 34
    • 0031770972 scopus 로고    scopus 로고
    • Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease
    • 9768655 1:CAS:528:DyaK1cXmsFKltLk%3D 10.1210/jc.83.10.3507
    • S. Laureti, A. De Bellis, V.I. Muccitelli et al., Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease. J. Clin. Endocrinol. Metab. 83, 3507-3511 (1998)
    • (1998) J. Clin. Endocrinol. Metab. , vol.83 , pp. 3507-3511
    • Laureti, S.1    De Bellis, A.2    Muccitelli, V.I.3
  • 35
    • 33646424095 scopus 로고    scopus 로고
    • Estimated risk for developing autoimmune Addison's disease in patients with adrenal cortex autoantibodies
    • 16522688 1:CAS:528:DC%2BD28XkslCntrg%3D 10.1210/jc.2005-0860
    • G. Coco, C. Dal Pra, F. Presotto et al., Estimated risk for developing autoimmune Addison's disease in patients with adrenal cortex autoantibodies. J. Clin. Endocrinol. Metab. 91, 1637-1645 (2006)
    • (2006) J. Clin. Endocrinol. Metab. , vol.91 , pp. 1637-1645
    • Coco, G.1    Dal Pra, C.2    Presotto, F.3
  • 36
    • 78649529448 scopus 로고    scopus 로고
    • Endocrine organs under the control of the immune system: Potential implications for cellular therapies
    • 21132622 1:CAS:528:DC%2BC3cXhs1art7fI 10.1055/s-0030-1268457
    • B. Jacobs, C. Papewalis, M. Ehlers, M. Schott, Endocrine organs under the control of the immune system: potential implications for cellular therapies. Horm. Metab. Res. 42, 912-917 (2010)
    • (2010) Horm. Metab. Res. , vol.42 , pp. 912-917
    • Jacobs, B.1    Papewalis, C.2    Ehlers, M.3    Schott, M.4
  • 37
    • 0025220699 scopus 로고
    • Polyglandular autoimmune syndrome type II in patients with idiopathic Addison's disease
    • 1:STN:280:DyaK3c3jvF2qsQ%3D%3D
    • K.I. Papadopoulos, B. Hallengren, Polyglandular autoimmune syndrome type II in patients with idiopathic Addison's disease. Acta Endocrinol. (Copenh.) 122, 472-478 (1990)
    • (1990) Acta Endocrinol. (Copenh.) , vol.122 , pp. 472-478
    • Papadopoulos, K.I.1    Hallengren, B.2
  • 38
    • 0025950871 scopus 로고
    • Association of Addison's disease with autoimmune disorders - A long-term observation of 180 patients
    • 1775423 1:STN:280:DyaK387jtFOguw%3D%3D 10.1136/pgmj.67.793.984
    • A.A. Kasperlik-Zaluska, B. Migdalska, B. Czarnocka, J. Drac-Kaniewska, E. Niegowska, W. Czech, Association of Addison's disease with autoimmune disorders - a long-term observation of 180 patients. Postgrad. Med. J. 67, 984-987 (1991)
    • (1991) Postgrad. Med. J. , vol.67 , pp. 984-987
    • Kasperlik-Zaluska, A.A.1    Migdalska, B.2    Czarnocka, B.3    Drac-Kaniewska, J.4    Niegowska, E.5    Czech, W.6
  • 39
    • 0028817212 scopus 로고
    • Associated autoimmunity in Addison's disease
    • 1:STN:280:DyaK2M3ltFOnug%3D%3D 10.1006/jaut.1995.0009
    • P.M. Zelissen, E.J. Bast, R.J. Croughs, Associated autoimmunity in Addison's disease. J. Autoimmunity 8, 121-130 (1995)
    • (1995) J. Autoimmunity , vol.8 , pp. 121-130
    • Zelissen, P.M.1    Bast, E.J.2    Croughs, R.J.3
  • 41
    • 2342458361 scopus 로고    scopus 로고
    • Autoimmune polyendocrine syndromes
    • 15141045 1:CAS:528:DC%2BD2cXktVGitLc%3D 10.1056/NEJMra030158
    • G.S. Eisenbarth, P.A. Gottlieb, Autoimmune polyendocrine syndromes. N. Engl. J. Med. 350, 2068-2079 (2004)
    • (2004) N. Engl. J. Med. , vol.350 , pp. 2068-2079
    • Eisenbarth, G.S.1    Gottlieb, P.A.2
  • 42
    • 1542269618 scopus 로고    scopus 로고
    • Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): A model disease to study molecular aspects of endocrine autoimmunity
    • 15008965 1:CAS:528:DC%2BD2cXislalsLo%3D 10.1111/j.1365-2249.2004.02384.x
    • P. Peterson, J. Pitkänen, N. Sillanpää, K. Krohn, Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a model disease to study molecular aspects of endocrine autoimmunity. Clin. Exp. Immunol. 135, 348-357 (2004)
    • (2004) Clin. Exp. Immunol. , vol.135 , pp. 348-357
    • Peterson, P.1    Pitkänen, J.2    Sillanpää, N.3    Krohn, K.4
  • 45
    • 46149091743 scopus 로고    scopus 로고
    • The association of genetic polymorphisms and autoimmune Addison's disease
    • 20477573 1:CAS:528:DC%2BD1cXnsFWrtbg%3D 10.1586/1744666X.4.4.441
    • A. Falorni, A. Brozzetti, D. La Torre, C. Tortoioli, G. Gambelunghe, The association of genetic polymorphisms and autoimmune Addison's disease. Expert Rev. Clin. Immunol. 4, 441-456 (2008)
    • (2008) Expert Rev. Clin. Immunol. , vol.4 , pp. 441-456
    • Falorni, A.1    Brozzetti, A.2    La Torre, D.3    Tortoioli, C.4    Gambelunghe, G.5
  • 47
    • 12544254677 scopus 로고    scopus 로고
    • Female preponderance in congenital adrenal hyperplasia due to CYP21 deficiency in England: Implications for neonatal screening
    • 15627780 10.1159/000082896 1:CAS:528:DC%2BD2MXksVOjuw%3D%3D
    • A. Nordenström, S. Ahmed, J. Jones, M. Coleman, D.A. Price, P.E. Clayton, C.M. Hall, Female preponderance in congenital adrenal hyperplasia due to CYP21 deficiency in England: implications for neonatal screening. Horm. Res. 63, 22-28 (2005)
    • (2005) Horm. Res. , vol.63 , pp. 22-28
    • Nordenström, A.1    Ahmed, S.2    Jones, J.3    Coleman, M.4    Price, D.A.5    Clayton, P.E.6    Hall, C.M.7
  • 48
    • 0030765127 scopus 로고    scopus 로고
    • Current status of neonatal screening for congenital adrenal hyperplasia
    • 9300201 1:STN:280:DyaK2svksFeitA%3D%3D 10.1097/00008480-199708000-00018
    • S. Pang, M.K. Shook, Current status of neonatal screening for congenital adrenal hyperplasia. Curr. Opin. Pediatr. 9, 419-423 (1997)
    • (1997) Curr. Opin. Pediatr. , vol.9 , pp. 419-423
    • Pang, S.1    Shook, M.K.2
  • 49
    • 0035028353 scopus 로고    scopus 로고
    • Newborn screening for congenital adrenal hyperplasia
    • 11344933 1:CAS:528:DC%2BD3MXjvVamsLk%3D 10.1016/S0889-8529(08)70017-3
    • B.L. Therrell, Newborn screening for congenital adrenal hyperplasia. Endocrinol. Metab. Clin. North Am. 30, 15-30 (2001)
    • (2001) Endocrinol. Metab. Clin. North Am. , vol.30 , pp. 15-30
    • Therrell, B.L.1
  • 50
    • 10344226651 scopus 로고    scopus 로고
    • Neonatal screening for congenital adrenal hyperplasia
    • 15554889 10.1530/eje.0.151U071
    • H.J. van der Kamp, J.M. Wit, Neonatal screening for congenital adrenal hyperplasia. Eur. J. Endocrinol. 151(Suppl 3), U71-U75 (2004)
    • (2004) Eur. J. Endocrinol. , vol.151 , Issue.SUPPL. 3
    • Van Der Kamp, H.J.1    Wit, J.M.2
  • 51
  • 53
    • 0037456430 scopus 로고    scopus 로고
    • Corticosteroid insufficiency in acutely ill patients
    • 12594318 1:CAS:528:DC%2BD3sXhtlWjtb0%3D 10.1056/NEJMra020529
    • M.S. Cooper, P.M. Stewart, Corticosteroid insufficiency in acutely ill patients. N. Engl. J. Med. 348, 727-734 (2003)
    • (2003) N. Engl. J. Med. , vol.348 , pp. 727-734
    • Cooper, M.S.1    Stewart, P.M.2
  • 54
    • 0033678507 scopus 로고    scopus 로고
    • Stimulatory effect of adrenocorticotropin on cortisol, aldosterone, and dehydroepiandrosterone secretion in normal humans: Dose-response study
    • 10999799 1:CAS:528:DC%2BD3cXmsVKru7Y%3D 10.1210/jc.85.9.3141
    • E. Arvat, L. Di Vito, F. Lanfranco, M. Maccario, C. Baffoni, R. Rossetto, G. Aimaretti, F. Camanni, E. Ghigo, Stimulatory effect of adrenocorticotropin on cortisol, aldosterone, and dehydroepiandrosterone secretion in normal humans: dose-response study. J. Clin. Endocrinol. Metab. 85, 3141-3146 (2000)
    • (2000) J. Clin. Endocrinol. Metab. , vol.85 , pp. 3141-3146
    • Arvat, E.1    Di Vito, L.2    Lanfranco, F.3    MacCario, M.4    Baffoni, C.5    Rossetto, R.6    Aimaretti, G.7    Camanni, F.8    Ghigo, E.9
  • 55
    • 0033846609 scopus 로고    scopus 로고
    • Low dose (1 microg) ACTH test in the evaluation of adrenal dysfunction in pre-clinical Addison's disease
    • 1:CAS:528:DC%2BD3cXlvF2jsb4%3D 10.1046/j.1365-2265.2000.01050.x
    • S. Laureti, E. Arvat, P. Candeloro, L. Di Vito, E. Ghigo, F. Santeusanio, A. Falorni, Low dose (1 microg) ACTH test in the evaluation of adrenal dysfunction in pre-clinical Addison's disease. Clin. Endocrinol. (Oxf.) 53, 107-115 (2000)
    • (2000) Clin. Endocrinol. (Oxf.) , vol.53 , pp. 107-115
    • Laureti, S.1    Arvat, E.2    Candeloro, P.3    Di Vito, L.4    Ghigo, E.5    Santeusanio, F.6    Falorni, A.7
  • 56
    • 0036423883 scopus 로고    scopus 로고
    • Dehydroepiandrosterone, 17alpha-hydroxyprogesterone and aldosterone responses to the low-dose (1 micro g) ACTH test in subjects with preclinical adrenal autoimmunity
    • 1:CAS:528:DC%2BD38XptVGnsr4%3D 10.1046/j.1365-2265.2002.01651.x
    • S. Laureti, P. Candeloro, M.C. Aglietti, R. Giordano, E. Arvat, E. Ghigo, F. Santeusanio, A. Falorni, Dehydroepiandrosterone, 17alpha-hydroxyprogesterone and aldosterone responses to the low-dose (1 micro g) ACTH test in subjects with preclinical adrenal autoimmunity. Clin. Endocrinol. (Oxf.) 57, 677-683 (2002)
    • (2002) Clin. Endocrinol. (Oxf.) , vol.57 , pp. 677-683
    • Laureti, S.1    Candeloro, P.2    Aglietti, M.C.3    Giordano, R.4    Arvat, E.5    Ghigo, E.6    Santeusanio, F.7    Falorni, A.8
  • 57
    • 11144354944 scopus 로고    scopus 로고
    • Italian Addison Network Study: Update of diagnostic criteria for the etiological classification of primary adrenal insufficiency
    • 15070918 1:CAS:528:DC%2BD2cXjt1elsLw%3D 10.1210/jc.2003-030954
    • A. Falorni, S. Laureti, A. De Bellis et al., Italian Addison Network Study: update of diagnostic criteria for the etiological classification of primary adrenal insufficiency. J. Clin. Endocrinol. Metab. 89, 1598-1604 (2004)
    • (2004) J. Clin. Endocrinol. Metab. , vol.89 , pp. 1598-1604
    • Falorni, A.1    Laureti, S.2    De Bellis, A.3
  • 59
    • 64249161198 scopus 로고    scopus 로고
    • Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type i
    • 19382991 1:CAS:528:DC%2BD1MXlvFOit70%3D 10.1111/j.1365-2796.2009.02090.x
    • E.S. Husebye, J. Perheentupa, R. Rautemaa, O. Kämpe, Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. J. Intern. Med. 265, 514-529 (2009)
    • (2009) J. Intern. Med. , vol.265 , pp. 514-529
    • Husebye, E.S.1    Perheentupa, J.2    Rautemaa, R.3    Kämpe, O.4
  • 60
    • 0036329603 scopus 로고    scopus 로고
    • Steroid-cell autoantibodies are preferentially expressed in women with premature ovarian failure who have adrenal autoimmunity
    • 12137862 10.1016/S0015-0282(02)03205-3
    • A. Falorni, S. Laureti, P. Candeloro et al., Steroid-cell autoantibodies are preferentially expressed in women with premature ovarian failure who have adrenal autoimmunity. Fertil. Steril. 78, 270-279 (2002)
    • (2002) Fertil. Steril. , vol.78 , pp. 270-279
    • Falorni, A.1    Laureti, S.2    Candeloro, P.3
  • 62
    • 80051794839 scopus 로고    scopus 로고
    • Measuring adrenal autoantibody response: Interlaboratory concordance in the first international serum exchange for the determination of 21-hydroxylase autoantibodies
    • 21570358 1:CAS:528:DC%2BC3MXhtVKltLrO 10.1016/j.clim.2011.04.012
    • A. Falorni, S. Chen, R. Zanchetta, L. Yu, C. Tiberti, M.L. Bacosi, J. Furmaniak, V. Bini, F. Dotta, G.S. Eisenbarth, B.R. Smith, C. Betterle, Measuring adrenal autoantibody response: interlaboratory concordance in the first international serum exchange for the determination of 21-hydroxylase autoantibodies. Clin. Immunol. 140, 291-299 (2011)
    • (2011) Clin. Immunol. , vol.140 , pp. 291-299
    • Falorni, A.1    Chen, S.2    Zanchetta, R.3    Yu, L.4    Tiberti, C.5    Bacosi, M.L.6    Furmaniak, J.7    Bini, V.8    Dotta, F.9    Eisenbarth, G.S.10    Smith, B.R.11    Betterle, C.12
  • 63
    • 0346366730 scopus 로고    scopus 로고
    • Replacement therapy in Addison's disease
    • 14640913 1:CAS:528:DC%2BD3sXptlemtbs%3D 10.1517/14656566.4.12.2145
    • K. Lovas, E.S. Husebye, Replacement therapy in Addison's disease. Expert Opin. Pharmacother. 4, 2145-2149 (2003)
    • (2003) Expert Opin. Pharmacother. , vol.4 , pp. 2145-2149
    • Lovas, K.1    Husebye, E.S.2
  • 64
    • 0038054450 scopus 로고    scopus 로고
    • Adrenal insufficiency
    • 12788587 1:CAS:528:DC%2BD3sXkt1artr0%3D 10.1016/S0140-6736(03)13492-7
    • W. Arlt, B. Allolio, Adrenal insufficiency. Lancet 361, 1881-1893 (2003)
    • (2003) Lancet , vol.361 , pp. 1881-1893
    • Arlt, W.1    Allolio, B.2
  • 65
    • 0026096434 scopus 로고
    • Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry
    • 1986026 1:STN:280:DyaK3M%2Fptlertw%3D%3D 10.1210/jcem-72-1-39
    • N.V. Esteban, T. Loughlin, A.L. Yergay, J.K. Zawadki, J.D. Booth, J.C. Winterer et al., Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J. Clin. Endocrinol. Metab. 72, 39-45 (1991)
    • (1991) J. Clin. Endocrinol. Metab. , vol.72 , pp. 39-45
    • Esteban, N.V.1    Loughlin, T.2    Yergay, A.L.3    Zawadki, J.K.4    Booth, J.D.5    Winterer, J.C.6
  • 66
    • 33749578271 scopus 로고    scopus 로고
    • The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients
    • 16895963 1:CAS:528:DC%2BD28XhtFSjtbzP 10.1210/jc.2006-0524
    • H. Filipsson, J.P. Monson, M. Koltowska-Häggström, A. Mattsson, G. Johansson, The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. J. Clin. Endocrinol. Metab. 91, 3954-3961 (2006)
    • (2006) J. Clin. Endocrinol. Metab. , vol.91 , pp. 3954-3961
    • Filipsson, H.1    Monson, J.P.2    Koltowska-Häggström, M.3    Mattsson, A.4    Johansson, G.5
  • 67
    • 33644948808 scopus 로고    scopus 로고
    • Assessing the HPA axis in patients with pituitary disease: A UK survey
    • 10.1111/j.1365-2265.2005.02421.x
    • R.M. Reynolds, P.M. Stewart, J.R. Seckl, P.L. Padfield, Assessing the HPA axis in patients with pituitary disease: a UK survey. Clin. Endocrinol. (Oxf) 64, 82-85 (2006)
    • (2006) Clin. Endocrinol. (Oxf) , vol.64 , pp. 82-85
    • Reynolds, R.M.1    Stewart, P.M.2    Seckl, J.R.3    Padfield, P.L.4
  • 68
    • 0019777580 scopus 로고
    • Patterns of plasma cortisol and ACTH concentrations in patients with Addison's disease treated with conventional corticosteroid replacement
    • 1:STN:280:DyaL38%2FntVOksA%3D%3D 10.1111/j.1365-2265.1981.tb00634.x
    • C.M. Feek, J.G. Ratcliffe, J. Seth, C.E. Gray, A.D. Toft, W.J. Irvine, Patterns of plasma cortisol and ACTH concentrations in patients with Addison's disease treated with conventional corticosteroid replacement. Clin. Endocrinol. (Oxf.) 14, 451-458 (1981)
    • (1981) Clin. Endocrinol. (Oxf.) , vol.14 , pp. 451-458
    • Feek, C.M.1    Ratcliffe, J.G.2    Seth, J.3    Gray, C.E.4    Toft, A.D.5    Irvine, W.J.6
  • 69
    • 0018228302 scopus 로고
    • Plasma ACTH and cortisol profiles in Addisonian patients receiving conventional substitution therapy
    • 1:STN:280:DyaE1M7kslGisw%3D%3D 10.1111/j.1365-2265.1978.tb01516.x
    • R.S. Scott, R.A. Donald, E.A. Espiner, Plasma ACTH and cortisol profiles in Addisonian patients receiving conventional substitution therapy. Clin. Endocrinol. (Oxf.) 9, 571-576 (1978)
    • (1978) Clin. Endocrinol. (Oxf.) , vol.9 , pp. 571-576
    • Scott, R.S.1    Donald, R.A.2    Espiner, E.A.3
  • 70
    • 0033020447 scopus 로고    scopus 로고
    • Assessment of corticosteroid replacement therapy in adults with adrenal insufficiency
    • 10370729 1:CAS:528:DyaK1MXitFyks78%3D
    • W. Jeffcoate, Assessment of corticosteroid replacement therapy in adults with adrenal insufficiency. Ann. Clin. Biochem. 36(2), 151-157 (1999)
    • (1999) Ann. Clin. Biochem. , vol.36 , Issue.2 , pp. 151-157
    • Jeffcoate, W.1
  • 71
    • 1042269521 scopus 로고    scopus 로고
    • Improvement of treatment of primary adrenal insufficiency by administration of cortisone acetate in three daily doses
    • 15008243 1:CAS:528:DC%2BD2cXitlOksLo%3D
    • S. Laureti, A. Falorni, F. Santeusanio, Improvement of treatment of primary adrenal insufficiency by administration of cortisone acetate in three daily doses. J. Endocrinol. Invest. 26, 1071-1075 (2003)
    • (2003) J. Endocrinol. Invest. , vol.26 , pp. 1071-1075
    • Laureti, S.1    Falorni, A.2    Santeusanio, F.3
  • 72
    • 33644904603 scopus 로고    scopus 로고
    • Quality of glucocorticoid replacement in adrenal insufficiency: Clinical assessment vs. timed serum cortisol measurements
    • W. Arlt, C. Rosenthal, S. Hahner, B. Allolio: Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements. Clin. Endocrinol. (Oxf.) 64, 384-389 (2006)
    • (2006) Clin. Endocrinol. (Oxf.) , vol.64 , pp. 384-389
    • Arlt, W.1    Rosenthal, C.2    Hahner, S.3    Allolio, B.4
  • 73
    • 4644312360 scopus 로고    scopus 로고
    • Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency
    • 1:CAS:528:DC%2BD2cXpsVSitb0%3D 10.1111/j.1365-2265.2004.02106.x
    • P.M. Mah, R.C. Jenkins, A. Rostami-Hodjegan, J. Newell-Price, A. Doane et al., Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. Clin. Endocrinol. (Oxf.) 61, 367-375 (2004)
    • (2004) Clin. Endocrinol. (Oxf.) , vol.61 , pp. 367-375
    • Mah, P.M.1    Jenkins, R.C.2    Rostami-Hodjegan, A.3    Newell-Price, J.4    Doane, A.5
  • 74
    • 0023889489 scopus 로고
    • Heritability of variation of plasma cortisol levels
    • 2967419 1:CAS:528:DyaL1cXhvVSgu7o%3D 10.1016/0026-0495(88)90164-3
    • A.W. Meikle, J.D. Stringham, M.G. Woodward, D.T. Bishop, Heritability of variation of plasma cortisol levels. Metabolism 37, 514-517 (1988)
    • (1988) Metabolism , vol.37 , pp. 514-517
    • Meikle, A.W.1    Stringham, J.D.2    Woodward, M.G.3    Bishop, D.T.4
  • 75
    • 0017342465 scopus 로고
    • Serum cortisol appearance-disappearance in adrenal insufficiency after oral cortisone acetate
    • 1:STN:280:DyaE2s7jtV2lsg%3D%3D
    • A.L. Barbato, R.L. Landau, Serum cortisol appearance-disappearance in adrenal insufficiency after oral cortisone acetate. Acta Endocrinol. (Copenh.) 84, 600-604 (1977)
    • (1977) Acta Endocrinol. (Copenh.) , vol.84 , pp. 600-604
    • Barbato, A.L.1    Landau, R.L.2
  • 76
    • 0023677584 scopus 로고
    • Corticosteroid replacement therapy: Twice or thrice daily?
    • 3184107 1:STN:280:DyaL1M%2FjslSnsQ%3D%3D
    • R.W. Groves, G.C. Toms, B.J. Hougthon, J.P. Monson, Corticosteroid replacement therapy: twice or thrice daily? J.R.Soc.Med. 81, 514-516 (1988)
    • (1988) J.R.Soc.Med. , vol.81 , pp. 514-516
    • Groves, R.W.1    Toms, G.C.2    Hougthon, B.J.3    Monson, J.P.4
  • 77
    • 31544457057 scopus 로고    scopus 로고
    • Comparison of different regimens of glucocorticoid replacement therapy in patients with hypoadrenalism
    • 16218046 1:CAS:528:DC%2BD2MXhtFeksb7L
    • L. Barbetta, C. Dall'Asta, T. Re, R. Libè, E. Costa, B. Ambrosi, Comparison of different regimens of glucocorticoid replacement therapy in patients with hypoadrenalism. J. Endocrinol. Invest. 28, 632-637 (2005)
    • (2005) J. Endocrinol. Invest. , vol.28 , pp. 632-637
    • Barbetta, L.1    Dall'Asta, C.2    Re, T.3    Libè, R.4    Costa, E.5    Ambrosi, B.6
  • 78
    • 0030906125 scopus 로고    scopus 로고
    • An assessment of optimal hydrocortisone replacement therapy
    • 1:CAS:528:DyaK2sXjt1enur4%3D 10.1046/j.1365-2265.1997.1340955.x
    • T.A. Howlett, An assessment of optimal hydrocortisone replacement therapy. Clin. Endocrinol. (Oxf.) 46, 263-268 (1997)
    • (1997) Clin. Endocrinol. (Oxf.) , vol.46 , pp. 263-268
    • Howlett, T.A.1
  • 79
    • 34347369577 scopus 로고    scopus 로고
    • Variability in hydrocortisone plasma and saliva pharmacokinetics following intravenous and oral administration to patients with adrenal insufficiency
    • 1:CAS:528:DC%2BD2sXotlSiu7k%3D 10.1111/j.1365-2265.2007.02812.x
    • A.H. Thomson, M.C. Devers, A.M. Wallace, D. Grant, K. Campbell et al., Variability in hydrocortisone plasma and saliva pharmacokinetics following intravenous and oral administration to patients with adrenal insufficiency. Clin. Endocrinol. (Oxf.) 66, 789-796 (2007)
    • (2007) Clin. Endocrinol. (Oxf.) , vol.66 , pp. 789-796
    • Thomson, A.H.1    Devers, M.C.2    Wallace, A.M.3    Grant, D.4    Campbell, K.5
  • 80
    • 0035068588 scopus 로고    scopus 로고
    • Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    • 11250647 1:CAS:528:DC%2BD3MXislaqt78%3D 10.1677/joe.0.1690065
    • E. Charmandari, A. Johnston, C.G. Brook, P.C. Hindmarsh, Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Endocrinol. 169, 65-70 (2001)
    • (2001) J. Endocrinol. , vol.169 , pp. 65-70
    • Charmandari, E.1    Johnston, A.2    Brook, C.G.3    Hindmarsh, P.C.4
  • 81
    • 35948976968 scopus 로고    scopus 로고
    • Measurement of cortisol in human hair as a biomarker of systemic exposure
    • 17892760 1:CAS:528:DC%2BD1cXntV2ktrk%3D
    • B. Sauve, G. Koren, G. Walsh, S. Tokmakejian, S.H. Van Uum, Measurement of cortisol in human hair as a biomarker of systemic exposure. Clin. Invest. Med. 30, E183-E191 (2007)
    • (2007) Clin. Invest. Med. , vol.30
    • Sauve, B.1    Koren, G.2    Walsh, G.3    Tokmakejian, S.4    Van Uum, S.H.5
  • 82
    • 0035021042 scopus 로고    scopus 로고
    • Human saliva as a diagnostic specimen
    • 11340128 1:STN:280:DC%2BD3Mzis1eitA%3D%3D
    • L.F. Hofman, Human saliva as a diagnostic specimen. J. Nutr. 131, 1621S-1625S (2001)
    • (2001) J. Nutr. , vol.131
    • Hofman, L.F.1
  • 83
    • 67349206144 scopus 로고    scopus 로고
    • De Oliveira Lima Arsati, Y.B., da Silva, D.A. de Araujo, V.C. Salivary cortisol in top-level professional soccer players
    • 19159948 1:CAS:528:DC%2BD1MXkvValtL0%3D 10.1007/s00421-009-0984-y
    • A. Moreira, F. Arsati, de Oliveira Lima Arsati, Y.B., da Silva, D.A. de Araujo, V.C. Salivary cortisol in top-level professional soccer players. Eur. J. Appl. Physiol. 106, 25-30 (2009)
    • (2009) Eur. J. Appl. Physiol. , vol.106 , pp. 25-30
    • Moreira, A.1    Arsati, F.2
  • 84
    • 0020791718 scopus 로고
    • Salivary steroid assays for assessing variation in endocrine activity
    • 6887863 1:CAS:528:DyaL3sXlsFahurc%3D 10.1016/S0022-4731(83)80035-1
    • D. Riad-Fahmy, G.F. Read, R.F. Walker, Salivary steroid assays for assessing variation in endocrine activity. J. Steroid Biochem. 19, 265-272 (1983)
    • (1983) J. Steroid Biochem. , vol.19 , pp. 265-272
    • Riad-Fahmy, D.1    Read, G.F.2    Walker, R.F.3
  • 85
    • 55349108859 scopus 로고    scopus 로고
    • Current status of salivary hormone analysis
    • 18757583 10.1373/clinchem.2008.108910 1:CAS:528:DC%2BD1cXhtlansrzO
    • M. Groschl, Current status of salivary hormone analysis. Clin. Chem. 54, 1759-1769 (2008)
    • (2008) Clin. Chem. , vol.54 , pp. 1759-1769
    • Groschl, M.1
  • 86
    • 78049500486 scopus 로고    scopus 로고
    • Salivary cortisone is a potential biomarker for serum free cortisol
    • 20685855 1:CAS:528:DC%2BC3cXhsV2nsbjM 10.1210/jc.2010-1215
    • I. Perogamvros, B.G. Keevil, D.W. Ray, P.J. Trainer, Salivary cortisone is a potential biomarker for serum free cortisol. J. Clin. Endocrinol. Metab. 95, 4951-4958 (2010)
    • (2010) J. Clin. Endocrinol. Metab. , vol.95 , pp. 4951-4958
    • Perogamvros, I.1    Keevil, B.G.2    Ray, D.W.3    Trainer, P.J.4
  • 87
    • 34250368460 scopus 로고    scopus 로고
    • Salivary cortisol reflects serum cortisol: Analysis of circadian profiles
    • 17456296 1:CAS:528:DC%2BD2sXmslClurY%3D 10.1258/000456307780480954
    • L.D. Dorn, J.F. Lucke, T.L. Loucks, S.L. Berga, Salivary cortisol reflects serum cortisol: analysis of circadian profiles. Ann. Clin. Biochem. 44, 281-284 (2007)
    • (2007) Ann. Clin. Biochem. , vol.44 , pp. 281-284
    • Dorn, L.D.1    Lucke, J.F.2    Loucks, T.L.3    Berga, S.L.4
  • 88
    • 36348982304 scopus 로고    scopus 로고
    • Steroid analysis in saliva: An overview
    • 17268582
    • J.G. Lewis, Steroid analysis in saliva: an overview. Clin. Biochem. Rev. 27, 139-146 (2006)
    • (2006) Clin. Biochem. Rev. , vol.27 , pp. 139-146
    • Lewis, J.G.1
  • 89
    • 66249099841 scopus 로고    scopus 로고
    • Salivary steroid assays - Research or routine?
    • 19176642 1:CAS:528:DC%2BD1MXmvVOht7Y%3D 10.1258/acb.2008.008208
    • P. Wood, Salivary steroid assays - research or routine? Ann. Clin. Biochem. 46, 183-196 (2009)
    • (2009) Ann. Clin. Biochem. , vol.46 , pp. 183-196
    • Wood, P.1
  • 90
    • 33749548793 scopus 로고    scopus 로고
    • Cushing's Syndrome: Important issues in diagnosis and management
    • 16868050 1:CAS:528:DC%2BD28XhtFSjtLbF 10.1210/jc.2006-0997
    • J.W. Findling, H. Raff, Cushing's Syndrome: important issues in diagnosis and management. J. Clin. Endocrinol. Metab. 91, 3746-3753 (2006)
    • (2006) J. Clin. Endocrinol. Metab. , vol.91 , pp. 3746-3753
    • Findling, J.W.1    Raff, H.2
  • 91
    • 70349931666 scopus 로고    scopus 로고
    • Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency
    • 19602555 1:CAS:528:DC%2BD1MXht12ru7rK 10.1210/jc.2009-1166
    • H. Raff, Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency. J. Clin. Endocrinol. Metab. 94, 3647-3655 (2009)
    • (2009) J. Clin. Endocrinol. Metab. , vol.94 , pp. 3647-3655
    • Raff, H.1
  • 92
    • 84862689424 scopus 로고    scopus 로고
    • Salivary cortisol and the diagnosis of Cushing's syndrome: A coming age
    • 22457047 1:CAS:528:DC%2BC38XkvVWitrc%3D 10.1007/s12020-012-9661-8
    • H. Raff, Salivary cortisol and the diagnosis of Cushing's syndrome: a coming age. Endocrine 41, 353-354 (2012)
    • (2012) Endocrine , vol.41 , pp. 353-354
    • Raff, H.1
  • 93
    • 0025030002 scopus 로고
    • The increase in plasma and saliva cortisol levels in pregnancy is not due to the increase in corticosteroid-binding globulin levels
    • 2394772 1:CAS:528:DyaK3MXntFE%3D 10.1210/jcem-71-3-639
    • E.M. Scott, H.H. McGarrigle, G.C. Lachelin, The increase in plasma and saliva cortisol levels in pregnancy is not due to the increase in corticosteroid-binding globulin levels. J. Clin. Endocrinol. Metab. 71, 639-644 (1990)
    • (1990) J. Clin. Endocrinol. Metab. , vol.71 , pp. 639-644
    • Scott, E.M.1    McGarrigle, H.H.2    Lachelin, G.C.3
  • 94
    • 34447128712 scopus 로고    scopus 로고
    • Prolonged hypocortisolemia in hydrocortisone replacement regimens in adrenocorticotrophic hormone deficiency
    • 17576782 10.1542/peds.2006-2558
    • A.M. Maguire, G.R. Ambler, B. Moore, M. McLean, M.G. Falleti, C.T. Cowell, Prolonged hypocortisolemia in hydrocortisone replacement regimens in adrenocorticotrophic hormone deficiency. Pediatrics 120, e164-e171 (2007)
    • (2007) Pediatrics , vol.120
    • Maguire, A.M.1    Ambler, G.R.2    Moore, B.3    McLean, M.4    Falleti, M.G.5    Cowell, C.T.6
  • 95
    • 3242725737 scopus 로고    scopus 로고
    • Saliva and bloodspot cortisol: Novel sampling methods to assess hydrocortisone replacement therapy in hypoadrenal patients
    • 1:CAS:528:DC%2BD2cXmslKiuro%3D 10.1111/j.1365-2265.2004.02062.x
    • V. Wong, T. Yan, A. Donald, M. McLean, Saliva and bloodspot cortisol: novel sampling methods to assess hydrocortisone replacement therapy in hypoadrenal patients. Clin. Endocrinol. (Oxf.) 61, 131-137 (2004)
    • (2004) Clin. Endocrinol. (Oxf.) , vol.61 , pp. 131-137
    • Wong, V.1    Yan, T.2    Donald, A.3    McLean, M.4
  • 96
    • 33751059416 scopus 로고    scopus 로고
    • Saliva cortisol measurement: Simple and reliable assessment of the glucocorticoid replacement therapy in Addison's disease
    • 17033262
    • K. Lovås, T.E. Thorsten, E.S. Husebye, Saliva cortisol measurement: simple and reliable assessment of the glucocorticoid replacement therapy in Addison's disease. J. Endocrinol. Invest. 29, 727-731 (2006)
    • (2006) J. Endocrinol. Invest. , vol.29 , pp. 727-731
    • Lovås, K.1    Thorsten, T.E.2    Husebye, E.S.3
  • 97
    • 34547440947 scopus 로고    scopus 로고
    • Continuous subcutaneous hydrocortisone infusion in Addison's disease
    • 17609409 10.1530/EJE-07-0052 1:CAS:528:DC%2BD2sXosVKru7w%3D
    • K. Lovås, E.S. Husebye, Continuous subcutaneous hydrocortisone infusion in Addison's disease. Eur. J. Endocrinol. 157, 109-112 (2007)
    • (2007) Eur. J. Endocrinol. , vol.157 , pp. 109-112
    • Lovås, K.1    Husebye, E.S.2
  • 98
    • 43449092527 scopus 로고    scopus 로고
    • Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders
    • 18280810 1:CAS:528:DC%2BD1cXlvF2qsrc%3D 10.1016/j.clinbiochem.2008.01.015
    • P. Restituto, J.C. Galofre, M.J. Gil, C. Mugueta, S. Santos et al., Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders. Clin. Biochem. 41, 688-692 (2008)
    • (2008) Clin. Biochem. , vol.41 , pp. 688-692
    • Restituto, P.1    Galofre, J.C.2    Gil, M.J.3    Mugueta, C.4    Santos, S.5
  • 100
    • 52949096055 scopus 로고    scopus 로고
    • Sources of biological and methodological variation in salivary cortisol and their impact on measurement among healthy adults: A review
    • 18609093 1:CAS:528:DC%2BD1cXhtFOqsrvL 10.1080/00365510701819127
    • A.M. Hansen, A.H. Garde, R. Persson, Sources of biological and methodological variation in salivary cortisol and their impact on measurement among healthy adults: a review. Scand. J. Clin. Lab. Invest. 68, 448-458 (2008)
    • (2008) Scand. J. Clin. Lab. Invest. , vol.68 , pp. 448-458
    • Hansen, A.M.1    Garde, A.H.2    Persson, R.3
  • 102
    • 0034889843 scopus 로고    scopus 로고
    • Stability of salivary steroids: The influences of storage, food and dental care
    • 11522335 1:CAS:528:DC%2BD3MXmtV2ls7c%3D 10.1016/S0039-128X(01)00111-8
    • M. Groschl, R. Wagner, M. Rauh, H.G. Dorr, Stability of salivary steroids: the influences of storage, food and dental care. Steroids 66, 737-741 (2001)
    • (2001) Steroids , vol.66 , pp. 737-741
    • Groschl, M.1    Wagner, R.2    Rauh, M.3    Dorr, H.G.4
  • 103
    • 57649155179 scopus 로고    scopus 로고
    • Salivary cortisol levels in Brazilian citizens of distintc socioeconomic and cultural levels
    • 19120148 1:CAS:528:DC%2BD1MXht1Wgtrw%3D 10.1196/annals.1410.065
    • M.C. Garcia, A. de Souza, G.P. Bella, D.M. Grassi-Kassisse, A.P. Tacla, R.C. Sapadari-Bratfisch, Salivary cortisol levels in Brazilian citizens of distintc socioeconomic and cultural levels. Ann.N.Y.Acad.Sci. 1148, 504-508 (2008)
    • (2008) Ann.N.Y.Acad.Sci. , vol.1148 , pp. 504-508
    • Garcia, M.C.1    De Souza, A.2    Bella, G.P.3    Grassi-Kassisse, D.M.4    Tacla, A.P.5    Sapadari-Bratfisch, R.C.6
  • 104
    • 42749093685 scopus 로고    scopus 로고
    • Salivary cortisol, dehydroepiandrosterone, and testosterone interrelationships in healthy young males: A pilot study with implications for studies of aggressive behavior
    • 1:CAS:528:DC%2BD1cXlvVWnurc%3D 10.1016/j.psychres.2007.06.012
    • G.L. Brown, E.L. McGarvey, E.A. Schirtcliff, A. Keller, D.A. Granger, K. Flavin, Salivary cortisol, dehydroepiandrosterone, and testosterone interrelationships in healthy young males: a pilot study with implications for studies of aggressive behavior. Psychistry Res. 159, 67-76 (2008)
    • (2008) Psychistry Res. , vol.159 , pp. 67-76
    • Brown, G.L.1    McGarvey, E.L.2    Schirtcliff, E.A.3    Keller, A.4    Granger, D.A.5    Flavin, K.6
  • 106
    • 73949110155 scopus 로고    scopus 로고
    • Adrenal crisis in treated Addison's disease: A predictable but under-managed event
    • 19776201 1:CAS:528:DC%2BC3cXntFyjtA%3D%3D 10.1530/EJE-09-0559
    • K. White, W. Arlt, Adrenal crisis in treated Addison's disease: a predictable but under-managed event. Eur. J. Endocrinol. 162, 115-120 (2010)
    • (2010) Eur. J. Endocrinol. , vol.162 , pp. 115-120
    • White, K.1    Arlt, W.2
  • 107
    • 77950600244 scopus 로고    scopus 로고
    • Addison's disease in adults: Diagnosis and management
    • 10.1016/j.amjmed.2009.12.017
    • A.J. Chakera, B. Vaidya, Addison's disease in adults: diagnosis and management. Am. J. Medicine 123, 409-413 (2010)
    • (2010) Am. J. Medicine , vol.123 , pp. 409-413
    • Chakera, A.J.1    Vaidya, B.2
  • 108
    • 2942585270 scopus 로고    scopus 로고
    • Mineralocorticoid substitution in pregnant Addisonian women
    • 15233565 1:STN:280:DC%2BD2czjtFamuw%3D%3D
    • W. Oelkers, Mineralocorticoid substitution in pregnant Addisonian women. J. Endocrinol. Invest. 27, 406 (2004)
    • (2004) J. Endocrinol. Invest. , vol.27 , pp. 406
    • Oelkers, W.1
  • 109
    • 80054819662 scopus 로고    scopus 로고
    • Grapefruit juice and licorice increase cortisol availability in patients with Addison's disease
    • 21896619 1:CAS:528:DC%2BC3MXhsVGqs73N 10.1530/EJE-11-0518
    • P. Methlie, E.E. Husebye, S. Hustad, E.A. Lien, K. Løvås, Grapefruit juice and licorice increase cortisol availability in patients with Addison's disease. Eur. J. Endocrinol. 165, 761-769 (2011)
    • (2011) Eur. J. Endocrinol. , vol.165 , pp. 761-769
    • Methlie, P.1    Husebye, E.E.2    Hustad, S.3    Lien, E.A.4    Løvås, K.5
  • 110
    • 34548032179 scopus 로고    scopus 로고
    • Liquorice and soy sauce, a life-saving concoction in a patient with Addison's disease
    • 17594790 1:STN:280:DC%2BD2sznvVejuw%3D%3D 10.1258/000456307780945624
    • H. Cooper, B. Bhattacharya, V. Verma, A.J. McCulloch, W.S. Smellie, A.H. Heald, Liquorice and soy sauce, a life-saving concoction in a patient with Addison's disease. Ann. Clin. Biochem. 44, 397-399 (2007)
    • (2007) Ann. Clin. Biochem. , vol.44 , pp. 397-399
    • Cooper, H.1    Bhattacharya, B.2    Verma, V.3    McCulloch, A.J.4    Smellie, W.S.5    Heald, A.H.6
  • 111
    • 0142088897 scopus 로고    scopus 로고
    • Diagnosis and management of Addison's disease during pregnancy
    • 14594127 1:STN:280:DC%2BD3srhsFOlsA%3D%3D
    • B. Ambrosi, L. Barbetta, L. Morricone, Diagnosis and management of Addison's disease during pregnancy. J. Endocrinol. Invest. 26, 698-702 (2003)
    • (2003) J. Endocrinol. Invest. , vol.26 , pp. 698-702
    • Ambrosi, B.1    Barbetta, L.2    Morricone, L.3
  • 112
    • 0022921501 scopus 로고
    • A prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease
    • 2946952 1:STN:280:DyaL2s%2FmsV2juw%3D%3D 10.1056/NEJM198612113152405
    • E. Barrett-Connor, K.T. Khaw, S.S.C. Yen, A prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease. N. Engl. J. Med. 315, 1519-1524 (1986)
    • (1986) N. Engl. J. Med. , vol.315 , pp. 1519-1524
    • Barrett-Connor, E.1    Khaw, K.T.2    Yen, S.S.C.3
  • 113
    • 0028341050 scopus 로고
    • Physiological importance of dehydroepiandrosterone
    • 7911183 1:STN:280:DyaK2c3mtVOqsw%3D%3D 10.1016/S0140-6736(94)92587-9
    • P. Ebeling, V.A. Kiovisto, Physiological importance of dehydroepiandrosterone. Lancet 343, 1479-1481 (1994)
    • (1994) Lancet , vol.343 , pp. 1479-1481
    • Ebeling, P.1    Kiovisto, V.A.2
  • 114
    • 0026538290 scopus 로고
    • Postmenopausal bone loss in rheumatoid arthritis: Effect of estrogens and androgens
    • 1533677 1:CAS:528:DyaK38XisVyktbs%3D
    • P. Sambrook, J. Birmingham, D. Champion, P. Kelly, S. Kempler, J. Freund, J. Eisman, Postmenopausal bone loss in rheumatoid arthritis: effect of estrogens and androgens. J. Rheumatol. 19, 357-361 (1992)
    • (1992) J. Rheumatol. , vol.19 , pp. 357-361
    • Sambrook, P.1    Birmingham, J.2    Champion, D.3    Kelly, P.4    Kempler, S.5    Freund, J.6    Eisman, J.7
  • 115
    • 10244252830 scopus 로고    scopus 로고
    • Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism
    • 15636426
    • R. Libè, L. Barbetta, C. Dall'Asta, F. Salvaggio, C. Gala, P. Beck-Peccoz, B. Ambrosi, Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism. J. Endocrinol. Invest. 27, 736-741 (2004)
    • (2004) J. Endocrinol. Invest. , vol.27 , pp. 736-741
    • Libè, R.1    Barbetta, L.2    Dall'Asta, C.3    Salvaggio, F.4    Gala, C.5    Beck-Peccoz, P.6    Ambrosi, B.7
  • 117
    • 0034487898 scopus 로고    scopus 로고
    • Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial
    • 11134123 1:CAS:528:DC%2BD3MXis1CktA%3D%3D 10.1210/jc.85.12.4650
    • P.J. Hunt, E.M. Gurnell, F.A. Huppert, C. Richards, A.T. Prevost, J.A. Wass, J. Herbert, V.K. Chatterjee, Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J. Clin. Endocrinol. Metab. 85, 4650-4656 (2000)
    • (2000) J. Clin. Endocrinol. Metab. , vol.85 , pp. 4650-4656
    • Hunt, P.J.1    Gurnell, E.M.2    Huppert, F.A.3    Richards, C.4    Prevost, A.T.5    Wass, J.A.6    Herbert, J.7    Chatterjee, V.K.8
  • 119
    • 33845484034 scopus 로고    scopus 로고
    • Premature mortality in patients with Addison's disease: A population-based study
    • 16968806 1:CAS:528:DC%2BD28XhtlGru7zN 10.1210/jc.2006-0076
    • R. Bergthorsdottir, M. Leonsson-Zachrisson, A. Odén, G. Johannsson, Premature mortality in patients with Addison's disease: a population-based study. J. Clin. Endocrinol. Metab. 91, 4849-4853 (2006)
    • (2006) J. Clin. Endocrinol. Metab. , vol.91 , pp. 4849-4853
    • Bergthorsdottir, R.1    Leonsson-Zachrisson, M.2    Odén, A.3    Johannsson, G.4
  • 120
    • 54049151288 scopus 로고    scopus 로고
    • Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency
    • 10.1111/j.1365-2265.2008.03340.x
    • S. Bensing, L. Brandt, F. Tabaroj, O. Sjöberg, B. Nilsson, A. Ekbom, P. Blomqvist, O. Kämpe, Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency. Clin. Endocrinol. (Oxf.) 69, 697-704 (2008)
    • (2008) Clin. Endocrinol. (Oxf.) , vol.69 , pp. 697-704
    • Bensing, S.1    Brandt, L.2    Tabaroj, F.3    Sjöberg, O.4    Nilsson, B.5    Ekbom, A.6    Blomqvist, P.7    Kämpe, O.8
  • 122
    • 0025333249 scopus 로고
    • Premature mortality due to cardiovascular disease in hypopituitarism
    • 1973979 10.1016/0140-6736(90)91812-O
    • T. Rosén, B.A. Bengtsson, Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336, 285-288 (1990)
    • (1990) Lancet , vol.336 , pp. 285-288
    • Rosén, T.1    Bengtsson, B.A.2
  • 123
    • 0035835469 scopus 로고    scopus 로고
    • Association between premature mortality and hypopituitarism. West Midlands Propsective Hypopituitary Study Group
    • 11273062 1:STN:280:DC%2BD3M7nt12itw%3D%3D 10.1016/S0140-6736(00)04006-X
    • J.W. Tomlinson, N. Holden, R.K. Hills, K. Wheatley, R.N. Clayton, A.S. Bates, M.C. Sheppard, P.M. Stewart, Association between premature mortality and hypopituitarism. West Midlands Propsective Hypopituitary Study Group. Lancet 357, 425-431 (2001)
    • (2001) Lancet , vol.357 , pp. 425-431
    • Tomlinson, J.W.1    Holden, N.2    Hills, R.K.3    Wheatley, K.4    Clayton, R.N.5    Bates, A.S.6    Sheppard, M.C.7    Stewart, P.M.8
  • 124
    • 1842502935 scopus 로고    scopus 로고
    • Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients
    • 15069388 1:CAS:528:DC%2BD2cXivVeluro%3D 10.1016/j.jpeds.2003.12.036
    • J.L. Mills, L.B. Schonberger, D.K. Wysowski, P. Brown, S.J. Durako, C. Cox, F. Kong, J.E. Fradkin, Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients. J. Pediatr. 144, 430-436 (2004)
    • (2004) J. Pediatr. , vol.144 , pp. 430-436
    • Mills, J.L.1    Schonberger, L.B.2    Wysowski, D.K.3    Brown, P.4    Durako, S.J.5    Cox, C.6    Kong, F.7    Fradkin, J.E.8
  • 125
    • 0023119291 scopus 로고
    • Effect of short-term, low-dose corticosteroids on plasma lipoprotein lipids
    • 3493784 1:CAS:528:DyaL2sXhtlWqsLs%3D 10.1016/0021-9150(87)90117-1
    • W.H. Ettinger, H.F. Klinefelter, P.O. Kwiterovitch, Effect of short-term, low-dose corticosteroids on plasma lipoprotein lipids. Atherosclerosis 63, 167-172 (1987)
    • (1987) Atherosclerosis , vol.63 , pp. 167-172
    • Ettinger, W.H.1    Klinefelter, H.F.2    Kwiterovitch, P.O.3
  • 126
    • 24644523307 scopus 로고    scopus 로고
    • Glucocorticoid use and serum lipid levels in US adults: The Third National Health and Nutrition Examination Survey
    • 16082633 1:CAS:528:DC%2BD2MXpvVSlsbY%3D 10.1002/art.21329
    • H.K. Choi, J.D. Seeger, Glucocorticoid use and serum lipid levels in US adults: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 53, 528-535 (2005)
    • (2005) Arthritis Rheum. , vol.53 , pp. 528-535
    • Choi, H.K.1    Seeger, J.D.2
  • 127
    • 40349092811 scopus 로고    scopus 로고
    • The epidemiology of glucocorticoid-associated adverse events
    • 18349741 10.1097/BOR.0b013e3282f51031
    • A.K. McDonough, J.R. Curtis, K.G. Saag, The epidemiology of glucocorticoid-associated adverse events. Curr. Opin. Rheumatol. 20, 131-137 (2008)
    • (2008) Curr. Opin. Rheumatol. , vol.20 , pp. 131-137
    • McDonough, A.K.1    Curtis, J.R.2    Saag, K.G.3
  • 128
    • 39449099564 scopus 로고    scopus 로고
    • Recent corticosteroid use and recent disease activity: Independent determinants of coronary heart disease risk factors in systemic lupus erythematosus?
    • 18240259 1:CAS:528:DC%2BD1cXjt1yqs7w%3D 10.1002/art.23352
    • I. Karp, M. Abrahamowicz, P.R. Fortin, L. Pilote, C. Neville, C. Pineau et al., Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus? Arthritis Rheum. 59, 169-175 (2008)
    • (2008) Arthritis Rheum. , vol.59 , pp. 169-175
    • Karp, I.1    Abrahamowicz, M.2    Fortin, P.R.3    Pilote, L.4    Neville, C.5    Pineau, C.6
  • 129
    • 58649095526 scopus 로고    scopus 로고
    • Novel insights into glucocorticoid-mediated diabetogenic effects: Towards expansion of therapeutic options?
    • 19200161 10.1111/j.1365-2362.2008.02067.x 1:CAS:528:DC%2BD1MXjtFKntrk%3D
    • D.H. van Raalte, D.M. Ouwens, M. Diamant, Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options? Eur. J. Clin. Invest. 39, 81-93 (2009)
    • (2009) Eur. J. Clin. Invest. , vol.39 , pp. 81-93
    • Van Raalte, D.H.1    Ouwens, D.M.2    Diamant, M.3
  • 130
    • 84864575252 scopus 로고    scopus 로고
    • Recognizing and treating secondary osteoporosis
    • 22782006 1:CAS:528:DC%2BC38XhtFCrsb%2FO 10.1038/nrrheum.2012.93
    • K. Walker-Bone, Recognizing and treating secondary osteoporosis. Nat. Rev. Rheumatol. 8, 480-492 (2012)
    • (2012) Nat. Rev. Rheumatol. , vol.8 , pp. 480-492
    • Walker-Bone, K.1
  • 131
    • 81355148579 scopus 로고    scopus 로고
    • Drug-related hypertension and resistance to antihypertensive treatment: A call for action
    • 22002334 1:CAS:528:DC%2BC3MXhsVCksLfK 10.1097/HJH.0b013e32834c465d
    • G.P. Rossi, T.M. Seccia, C. Maniero, A.C. Pessina, Drug-related hypertension and resistance to antihypertensive treatment: a call for action. J. Hypertens. 29, 2295-2309 (2011)
    • (2011) J. Hypertens. , vol.29 , pp. 2295-2309
    • Rossi, G.P.1    Seccia, T.M.2    Maniero, C.3    Pessina, A.C.4
  • 132
    • 84867045026 scopus 로고    scopus 로고
    • Effects of glucocorticoids and exercise on pancreatic β cell function and diabetes development
    • doi: 10.1002/dmrr.2310
    • J.L. Beaudry, M.C. Riddell, Effects of glucocorticoids and exercise on pancreatic β cell function and diabetes development. Diabetes Metab. Res. Rev. doi: 10.1002/dmrr.2310 (2012)
    • (2012) Diabetes Metab. Res. Rev.
    • Beaudry, J.L.1    Riddell, M.C.2
  • 133
    • 0024550009 scopus 로고
    • Plasma lipoproteins and adrenocortical hormones in men - Positive association of low density lipoprotein cholesterol with plasma cortisol concentration
    • 2731374 1:CAS:528:DyaL1MXhs1KgtLs%3D 10.1016/0009-8981(89)90342-2
    • M.N. Nanjee, N.E. Miller, Plasma lipoproteins and adrenocortical hormones in men - positive association of low density lipoprotein cholesterol with plasma cortisol concentration. Clin. Chim. Acta 180, 113-120 (1989)
    • (1989) Clin. Chim. Acta , vol.180 , pp. 113-120
    • Nanjee, M.N.1    Miller, N.E.2
  • 134
    • 0030790213 scopus 로고    scopus 로고
    • Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy
    • 9253349 1:CAS:528:DyaK2sXltFGmsb4%3D 10.1210/jc.82.8.2653
    • K.A. al-Shoumer, K.H. Cox, C.L. Hughes, W. Richmond, D.G. Johnston, Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy. J.Clin.Endocrinol.Metab. 82, 2653-2659 (1997)
    • (1997) J.Clin.Endocrinol.Metab. , vol.82 , pp. 2653-2659
    • Al-Shoumer, K.A.1    Cox, K.H.2    Hughes, C.L.3    Richmond, W.4    Johnston, D.G.5
  • 135
    • 0026484137 scopus 로고
    • Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults
    • 1359261 1:STN:280:DyaK3s%2FmtFGrtg%3D%3D 10.1016/0140-6736(92)92892-J
    • V. Markussis, S.A. Beshyah, C. Fisher, P. Sharp, A.N. Nicolaides, D.G. Johnston, Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet 340, 1188-1192 (1992)
    • (1992) Lancet , vol.340 , pp. 1188-1192
    • Markussis, V.1    Beshyah, S.A.2    Fisher, C.3    Sharp, P.4    Nicolaides, A.N.5    Johnston, D.G.6
  • 138
    • 0023090570 scopus 로고
    • Bone mineral density in Addison's disease: Evidence for an effect of adrenal androgens on bone mass
    • J.P. Devogelaer, J. Crabbé, C. Nagant de Deuxchaisnes, Bone mineral density in Addison's disease: evidence for an effect of adrenal androgens on bone mass. Br. Med. J. (Clin. Res. Ed.) 294, 798-800 (1987)
    • (1987) Br. Med. J. (Clin. Res. Ed.) , vol.294 , pp. 798-800
    • Devogelaer, J.P.1    Crabbé, J.2    Deuxchaisnes De C.Nagant3
  • 139
    • 0028085314 scopus 로고
    • Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease
    • 8273983 1:STN:280:DyaK2c%2FpvFGksQ%3D%3D 10.7326/0003-4819-120-3- 199402010-00005
    • P.M. Zelissen, R.J. Croughs, P.P. van Rijk, J.A. Raymakers, Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease. Ann. Intern. Med. 120, 207-210 (1994)
    • (1994) Ann. Intern. Med. , vol.120 , pp. 207-210
    • Zelissen, P.M.1    Croughs, R.J.2    Van Rijk, P.P.3    Raymakers, J.A.4
  • 140
    • 0028778868 scopus 로고
    • Bone mineral density is reduced in female but not male subjects with Addison's disease
    • 8115069 1:STN:280:DyaK2c7lvFamtA%3D%3D
    • C.M. Florkowski, S.J. Holmes, J.R. Elliot, R.A. Donald, E.A. Espiner, Bone mineral density is reduced in female but not male subjects with Addison's disease. N. Z. Med. J. 107, 52-53 (1994)
    • (1994) N. Z. Med. J. , vol.107 , pp. 52-53
    • Florkowski, C.M.1    Holmes, S.J.2    Elliot, J.R.3    Donald, R.A.4    Espiner, E.A.5
  • 143
    • 0033391671 scopus 로고    scopus 로고
    • Bone mineral density in patients with treated Addison's disease
    • 10663342 1:STN:280:DC%2BD3c7ltlaqsg%3D%3D 10.1007/s001980050251
    • G.D. Braatvedt, M. Joyce, M. Evans, J. Clearwater, I.R. Reid, Bone mineral density in patients with treated Addison's disease. Osteoporos. Int. 10, 435-440 (1999)
    • (1999) Osteoporos. Int. , vol.10 , pp. 435-440
    • Braatvedt, G.D.1    Joyce, M.2    Evans, M.3    Clearwater, J.4    Reid, I.R.5
  • 145
    • 3242816261 scopus 로고    scopus 로고
    • An assessment of bone mineral density in patients with Addison's disease and isolated ACTH deficiency treated with glucocorticoid
    • 15256782 1:CAS:528:DC%2BD2cXnvVyjsbY%3D 10.1507/endocrj.51.355
    • N. Chikada, T. Imaki, M. Hotta, K. Sato, K. Takano, An assessment of bone mineral density in patients with Addison's disease and isolated ACTH deficiency treated with glucocorticoid. Endocr. J. 51, 355-360 (2004)
    • (2004) Endocr. J. , vol.51 , pp. 355-360
    • Chikada, N.1    Imaki, T.2    Hotta, M.3    Sato, K.4    Takano, K.5
  • 147
    • 77955341031 scopus 로고    scopus 로고
    • Co-morbidities, management and clinical outcome of auto-immune Addison's disease
    • 20960111 1:CAS:528:DC%2BC3cXotlCms7w%3D 10.1007/s12020-010-9359-8
    • L. Leelarathna, L. Breen, J.K. Powrie, S.M. Thomas, R. Guzder, B. McGowan, P.V. Carroll, Co-morbidities, management and clinical outcome of auto-immune Addison's disease. Endocrine 38, 113-117 (2010)
    • (2010) Endocrine , vol.38 , pp. 113-117
    • Leelarathna, L.1    Breen, L.2    Powrie, J.K.3    Thomas, S.M.4    Guzder, R.5    McGowan, B.6    Carroll, P.V.7
  • 150
    • 84855479400 scopus 로고    scopus 로고
    • Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy
    • 21994966 1:CAS:528:DC%2BC38XhsVKrtbs%3D 10.1210/jc.2011-2036
    • K.R. Koetz, M. Ventz, S. Diederich, M. Quinkler, Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy. J. Clin. Endocrinol. Metab. 97, 85-92 (2012)
    • (2012) J. Clin. Endocrinol. Metab. , vol.97 , pp. 85-92
    • Koetz, K.R.1    Ventz, M.2    Diederich, S.3    Quinkler, M.4
  • 152
    • 17144470389 scopus 로고    scopus 로고
    • Subjective health status in Norwegian patients with Addison's disease
    • 10.1046/j.1365-2265.2002.01466.x
    • K. Lovas, J.H. Loge, E.S. Husebye, Subjective health status in Norwegian patients with Addison's disease. Clin. Endocrinol. (Oxf.) 56, 581-588 (2002)
    • (2002) Clin. Endocrinol. (Oxf.) , vol.56 , pp. 581-588
    • Lovas, K.1    Loge, J.H.2    Husebye, E.S.3
  • 153
    • 35348987031 scopus 로고    scopus 로고
    • Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis
    • 17684047 1:CAS:528:DC%2BD2sXht1SmtbbI 10.1210/jc.2007-0685
    • S. Hahner, M. Loeffler, M. Fassnacht, D. Weismann, A.C. Koschker, M. Quinkler et al., Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. J. Clin. Endocrinol. Metab. 92, 3912-3922 (2007)
    • (2007) J. Clin. Endocrinol. Metab. , vol.92 , pp. 3912-3922
    • Hahner, S.1    Loeffler, M.2    Fassnacht, M.3    Weismann, D.4    Koschker, A.C.5    Quinkler, M.6
  • 154
    • 58149337414 scopus 로고    scopus 로고
    • Impaired subjective health status in chronic adrenal insufficiency: Impact of different glucocorticoid replacement regimens
    • 18819943 1:CAS:528:DC%2BD1MXptFCksA%3D%3D 10.1530/EJE-08-0578
    • B. Bleicken, S. Hahner, M. Loeffler, M. Ventz, B. Allolio, M. Quinkler, Impaired subjective health status in chronic adrenal insufficiency: impact of different glucocorticoid replacement regimens. Eur. J. Endocrinol. 159, 811-817 (2008)
    • (2008) Eur. J. Endocrinol. , vol.159 , pp. 811-817
    • Bleicken, B.1    Hahner, S.2    Loeffler, M.3    Ventz, M.4    Allolio, B.5    Quinkler, M.6
  • 155
    • 76149133631 scopus 로고    scopus 로고
    • Development of a disease-specific quality of life questionnaire in Addison's disease
    • 20016050 10.1210/jc.2009-1711 1:CAS:528:DC%2BC3cXitVaisr4%3D
    • K. Løvås, S. Curran, M. Oksnes, E.S. Husebye, F.A. Huppert, V.K. Chatterjee, Development of a disease-specific quality of life questionnaire in Addison's disease. J. Clin. Endocrinol. Metab. 95, 545-551 (2010)
    • (2010) J. Clin. Endocrinol. Metab. , vol.95 , pp. 545-551
    • Løvås, K.1    Curran, S.2    Oksnes, M.3    Husebye, E.S.4    Huppert, F.A.5    Chatterjee, V.K.6
  • 157
    • 0033912440 scopus 로고    scopus 로고
    • Bottomed out: Metabolic significance of the circadian trough in glucocorticoid concentrations
    • 10997607 1:CAS:528:DC%2BD3cXmsVSmtr0%3D 10.1038/sj.ijo.0801276
    • M.F. Dallman, S.F. Akana, S. Bhatnagar, M.E. Bell, A.M. Strack, Bottomed out: metabolic significance of the circadian trough in glucocorticoid concentrations. Int. J. Obes. Relat. Metab. Disord. 24(Suppl 2), S40-S46 (2000)
    • (2000) Int. J. Obes. Relat. Metab. Disord. , vol.24 , Issue.SUPPL. 2
    • Dallman, M.F.1    Akana, S.F.2    Bhatnagar, S.3    Bell, M.E.4    Strack, A.M.5
  • 159
    • 77749301587 scopus 로고    scopus 로고
    • A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortysone (Cortef) in the treatment of congenital adrenal hyperplasia
    • S. Verma, C. Vanryzin, N. Sinaii, M.S. Kim, L.K. Nieman, S. Ravindran, K.A. Calis, W. Arlt, R.J. Ross, D.P. Merke, A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortysone (Cortef) in the treatment of congenital adrenal hyperplasia. Clin. Endocrinol. (Oxf.) 72, 441-447 (2010)
    • (2010) Clin. Endocrinol. (Oxf.) , vol.72 , pp. 441-447
    • Verma, S.1    Vanryzin, C.2    Sinaii, N.3    Kim, M.S.4    Nieman, L.K.5    Ravindran, S.6    Calis, K.A.7    Arlt, W.8    Ross, R.J.9    Merke, D.P.10
  • 160
    • 0036129774 scopus 로고    scopus 로고
    • Effects of low-dose oral hydrocortisone replacement versus short-term reproduction of physiological serum cortisol concentrations on insulin action in adult-onset hypopituitarism
    • 1:CAS:528:DC%2BD38XitlWqu7c%3D 10.1046/j.0300-0664.2001.01447.x
    • E.M. McConnell, P.M. Bell, C. Ennis, D.R. Hadden, D.R. McCance, B. Sheridan, A.B. Atkinson, Effects of low-dose oral hydrocortisone replacement versus short-term reproduction of physiological serum cortisol concentrations on insulin action in adult-onset hypopituitarism. Clin. Endocrinol. (Oxf.) 56, 195-201 (2002)
    • (2002) Clin. Endocrinol. (Oxf.) , vol.56 , pp. 195-201
    • McConnell, E.M.1    Bell, P.M.2    Ennis, C.3    Hadden, D.R.4    McCance, D.R.5    Sheridan, B.6    Atkinson, A.B.7
  • 161
    • 0034527614 scopus 로고    scopus 로고
    • Glucocorticoid replacement is permissive for rapid eye movement sleep and sleep consolidation in patients with adrenal insufficiency
    • 11095454 1:CAS:528:DC%2BD3cXotlWnu7s%3D 10.1210/jc.85.11.4201
    • D. Garcia-Borreguero, T.A. Wehr, O. Larrosa, J.J. Granizo, D. Hardwick, G.P. Chrousos, T.C. Friedman, Glucocorticoid replacement is permissive for rapid eye movement sleep and sleep consolidation in patients with adrenal insufficiency. J. Clin. Endocrinol. Metab. 85, 4201-4206 (2000)
    • (2000) J. Clin. Endocrinol. Metab. , vol.85 , pp. 4201-4206
    • Garcia-Borreguero, D.1    Wehr, T.A.2    Larrosa, O.3    Granizo, J.J.4    Hardwick, D.5    Chrousos, G.P.6    Friedman, T.C.7
  • 162
    • 67650752161 scopus 로고    scopus 로고
    • Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: A pharmacokinetic study
    • 19383806 1:CAS:528:DC%2BD1MXovVKktbs%3D 10.1530/EJE-09-0170
    • G. Johannsson, R. Bergthorsdottir, A.G. Nilsson, H. Lennernas, T. Hedner, S. Skrtic, Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study. Eur. J. Endocrinol. 161, 119-130 (2009)
    • (2009) Eur. J. Endocrinol. , vol.161 , pp. 119-130
    • Johannsson, G.1    Bergthorsdottir, R.2    Nilsson, A.G.3    Lennernas, H.4    Hedner, T.5    Skrtic, S.6
  • 164
    • 29744469426 scopus 로고    scopus 로고
    • Dehydroepiandrosterone replacement in patients with Addison's disease has a bimodal effect on regulatory (CD4 + CD25hi and CD4 + FoxP3 +) T cells
    • 16252254 1:CAS:528:DC%2BD28XpsVGm 10.1002/eji.200526128
    • A.J. Coles, S. Thompson, A.L. Cox, S. Curran, E.M. Gurnell, V.K. Chatterjee, Dehydroepiandrosterone replacement in patients with Addison's disease has a bimodal effect on regulatory (CD4 + CD25hi and CD4 + FoxP3 +) T cells. Eur. J. Immunol. 35, 3694-3703 (2005)
    • (2005) Eur. J. Immunol. , vol.35 , pp. 3694-3703
    • Coles, A.J.1    Thompson, S.2    Cox, A.L.3    Curran, S.4    Gurnell, E.M.5    Chatterjee, V.K.6
  • 166
    • 17744387695 scopus 로고    scopus 로고
    • Time course of 21-hydroxylase antibodies and long-term remission of subclinical autoimmune adrenalitis after corticosteroid therapy: Case report
    • 10.1210/jc.86.2.675
    • A. De Bellis, A. Falorni, S. Laureti et al., Time course of 21-hydroxylase antibodies and long-term remission of subclinical autoimmune adrenalitis after corticosteroid therapy: case report. J. Clin. Endocrinol. Metab. 86, 675-678 (2001)
    • (2001) J. Clin. Endocrinol. Metab. , vol.86 , pp. 675-678
    • De Bellis, A.1    Falorni, A.2    Laureti, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.